TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 185 filers reported holding TG THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.21 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $660,440 | -64.5% | 79,000 | +5.3% | 0.60% | -64.1% |
| Q2 2023 | $1,863,000 | +469169.5% | 75,000 | -21.1% | 1.67% | +322.5% |
| Q1 2023 | $397 | -99.9% | 95,000 | 0.0% | 0.40% | 0.0% |
| Q3 2022 | $397,000 | -84.1% | 95,000 | +26.7% | 0.40% | -68.2% |
| Q3 2021 | $2,496,000 | -14.2% | 75,000 | 0.0% | 1.24% | +11.0% |
| Q2 2021 | $2,909,000 | -19.5% | 75,000 | 0.0% | 1.12% | -17.5% |
| Q1 2021 | $3,615,000 | +2.6% | 75,000 | 0.0% | 1.36% | +3.6% |
| Q4 2020 | $3,525,000 | +112.1% | 75,000 | 0.0% | 1.31% | +100.9% |
| Q3 2020 | $1,662,000 | +42.4% | 75,000 | 0.0% | 0.65% | +33.5% |
| Q2 2020 | $1,167,000 | +107.3% | 75,000 | +15.4% | 0.49% | +63.0% |
| Q1 2020 | $563,000 | -4.6% | 65,000 | 0.0% | 0.30% | +6.4% |
| Q4 2019 | $590,000 | – | 65,000 | – | 0.28% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 8,198,337 | $33,613,000 | 1.96% |
| GREAT POINT PARTNERS LLC | 3,000,000 | $12,300,000 | 1.56% |
| BRIDGER MANAGEMENT, LLC | 3,791,531 | $15,545,000 | 1.30% |
| Avoro Capital Advisors LLC | 4,750,000 | $19,475,000 | 1.16% |
| Opaleye Management Inc. | 550,000 | $2,255,000 | 0.84% |
| CREDIT AGRICOLE S A | 1,307,428 | $5,360,000 | 0.30% |
| Eversept Partners, LP | 65,000 | $266,500 | 0.14% |
| HIGHLAND CAPITAL MANAGEMENT LP | 453,360 | $1,859,000 | 0.14% |
| 683 Capital Management, LLC | 500,000 | $2,050,000 | 0.12% |
| Artal Group S.A. | 400,000 | $1,640,000 | 0.06% |